Connection

PAUL LING to Antigens, Viral

This is a "connection" page, showing publications PAUL LING has written about Antigens, Viral.
Connection Strength

0.581
  1. Lethal Hemorrhagic Disease and Clinical Illness Associated with Elephant Endotheliotropic Herpesvirus 1 Are Caused by Primary Infection: Implications for the Detection of Diagnostic Proteins. J Virol. 2020 01 17; 94(3).
    View in: PubMed
    Score: 0.149
  2. Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk. J Virol. 1995 Mar; 69(3):1944-50.
    View in: PubMed
    Score: 0.106
  3. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. J Virol. 1994 Sep; 68(9):5375-83.
    View in: PubMed
    Score: 0.103
  4. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc Natl Acad Sci U S A. 1993 Oct 15; 90(20):9237-41.
    View in: PubMed
    Score: 0.097
  5. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. J Virol. 1993 Jun; 67(6):2990-3003.
    View in: PubMed
    Score: 0.094
  6. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science. 1994 Jul 01; 265(5168):92-5.
    View in: PubMed
    Score: 0.025
  7. Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. Mol Cell Biol. 1995 Nov; 15(11):6150-9.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.